SlideShare uma empresa Scribd logo
1 de 23
Baixar para ler offline
Using qualitative and quantitative
data: how to structure your research
Daniel Ratchford
Quality Health – Chief Executive
daniel.ratchford@quality-health.co.uk or @danielratchford
Quality Health
A specialist health and social care research organisation, working for public, private and
not-for profit sectors, in the UK and overseas
 We design innovative data collection mechanisms to gather insight from patients, service
users, staff and other stakeholders
 We use our unique expertise and experience to collect, process, analyse and present
information in the most meaningful ways
 We work collaboratively with our clients to support service improvements, inform change,
influence policy, and improve outcomes
25/10/2019 2
We help our clients achieve high quality and positive outcomes
in health, social care and other services
Key steps in generating data for Patient Advocacy
Work out what the problem is
 E.g. Do you have policy ideas you need to back up with evidence?
 E.g. Do you want to test a theory about patient experience?
Consider the bigger picture
 What is already known?
 Is there other relevant research?
 Are other Patient Advocacy organisations planning anything similar?
Have a clear analysis strategy
 Make sure you know from the start how you will analyse the data
 What exactly do you want to show, and to whom?
 Will qualitative findings (e.g. stories) be more powerful than quantitative (e.g. numbers)?
25/10/2019 3
Be clear from the start how you want to use the data
Good data can help your organisation to…
Predict an outcome
 E.g. If patients’ care is changed, how will this affect their overall wellbeing?
Explain a cause or consequence
 E.g. What has caused patients to report a drop in the standards of care?
Evaluate policy
 E.g. what has been the impact on patients of a change in policy or a new procedure?
Describe service provision
 E.g. What does high quality care look like from a patient perspective?
Develop good practice
 E.g. What do patients say would improve their care?
Empower patients
 E.g. What are the best ways to enhance patients’ lives, and the lives of patients in the future?
25/10/2019 4
Work out what your problem is: don’t just run a survey
for the sake of it!
Some good examples of focused patient advocacy
research
European Cancer Patient Coalition
Cancer Associated Thrombosis Awareness Survey
Aims:
 To understand – and compare across countries – patients’ awareness of
CAT
 To map where, and when, patients get their information
 To identify gaps of information and support during the patient pathway
25/10/2019 5
Some good examples of focused patient advocacy
research
Acute Leukemia Advocates Network
ALAN Quality of Life Survey
Aims:
 To understand the quality of life of acute leukaemia patients at different
points in the patient journey
25/10/2019 6
Some good examples of focused patient advocacy
research
All.Can International
Survey of Waste and Inefficiency in Cancer Care
Aims:
 To gather the views of cancer patients and carers into areas of waste and
inefficiency in cancer care
 To gather examples of good practice, and areas for improvement
25/10/2019 7
Some good examples of focused patient advocacy
research
CML Advocates Network
CML Treatment Free Remission Survey
Aims:
 To understand the experiences of CML patients considering and
undertaking Treatment Free Remission
 To compare different patient groups
 To consider the impact of different interventions and communications in
this process
25/10/2019 8
Main types of research to generate data
Literature review and desk research
 Reviewing the main ideas and research relating to your area of interest
 Accessing existing relevant data sets
Quantitative research
 Questionnaires delivered on paper, on-line, in person or by phone
 Structured interviewing
Qualitative research
 In-depth interviews, in person or by phone
 Focus groups
 Workshops
25/10/2019 9
Many of the most successful research programmes
use a combination of the above
Main types of research to generate data – pros and cons
PROs
Literature review and desk research
 Well-respected academic approach
 Relatively cheap
 Doesn’t require external support
Quantitative research
 Best known and accepted research approach
 Gathers views from many patients
 Statistically significant results
Qualitative research
 Produces narrative rather than numbers
 Stories, quotes, and films can have more
impact in advocacy campaigns
25/10/2019 10
CONs
Literature review and desk research
 No new primary data
 Access to academic papers expensive
 Requires research skills
Quantitative research
 Can be expensive
 Sampling bias often an issue
 No depth behind the numbers
Qualitative research
 Expensive
 Usually only involves small numbers
 Difficult to argue it’s representative
Typical research outputs
 Data tables (from qualitative surveys)
 Written commentaries of findings
 Breakdowns
 Powerpoint presentations
 Infographics
 Thematic analyses of qualitative research
 Quotes from interviews
 Films of patient stories
 Improvement events
 Formal papers for scientific journals
 Press releases and advocacy campaigns
25/10/2019 11
You should be clear at the start about what you need,
and how it will be used
25/10/2019 12
Data
Tables
25/10/2019 13
Written commentaries of findings
25/10/2019 14
Main worries after the end of treatment *
- by Gender
*Respondents could select all answer options that applied (tick all that apply)
Q7 / base = all respondents - What are the main worries you had after your treatment ended?
Males (n=450) Females (n=560)
Presentations: a breakdown
Infographics
25/10/2019 15
25/10/2019 16
Thematic
analysis
25/10/2019 17
Journal articles
25/10/2019 18https://vimeo.com/292669223/4f1e532e76
Interviews
25/10/2019 19https://www.youtube.com/watch?v=1pRtBtpPLTw
Films of patient stories
Some common problems…and how to avoid them
Not involving patients
 Coproduction of research design
 Patients and patient advocates on Steering Groups
 Patients involved in reviewing and testing survey materials
Not focusing on a specific issue - being too ambitious in scope
 Identify the theme/issue you’re interested in
 Keep it short
 Don’t just run a survey for the sake of it!
Not knowing what’s already been done
 Talk to the experts
 Carry out some form of literature review
25/10/2019 20
Some common problems…and how to avoid them
Not knowing what others are doing
 Network with other patient advocacy groups, in other countries - It’s likely
someone else is interested in the same issue
Lack of testing and piloting before fieldwork
 Don’t rush into implementation
 Test survey materials thoroughly
 Formal Cognitive Testing always identifies issues
Asking the wrong people
 Think about the sample of patients you want to hear from
 Design your research framework to generate a representative sample
 Don’t just listen to the same old voices
25/10/2019 21
Some common problems…and how to avoid them
Choosing the wrong delivery mechanism
 Using an external agency can be expensive and add complexity
 But carrying our research in-house risks lack of independence; and most
organisations don’t have the skills and capacity
 There will be times where both of these are right: consider carefully for each
piece of research
Not knowing how you’ll use the results
 Be clear at the start about what you need, and how it will be used
25/10/2019 22
Talk as much as possible to other Patient Advocacy
Groups about their experiences
0201b rachford   using qualitative and quantitative data how to structure your research

Mais conteúdo relacionado

Mais procurados

Bridget Hopwood & Amanda Attwood
Bridget Hopwood & Amanda AttwoodBridget Hopwood & Amanda Attwood
Bridget Hopwood & Amanda Attwood
MRS
 

Mais procurados (20)

Pavitt ppi impact on clinical research vs1
Pavitt ppi impact on clinical research vs1Pavitt ppi impact on clinical research vs1
Pavitt ppi impact on clinical research vs1
 
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
Patients at the Centre for Health Research –  Patient, Carer and Public Invol...Patients at the Centre for Health Research –  Patient, Carer and Public Invol...
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
 
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
 
How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...
 
F3 patient engagement-2015philadelphia
F3 patient engagement-2015philadelphiaF3 patient engagement-2015philadelphia
F3 patient engagement-2015philadelphia
 
CER 2016 Jacoby stakeholder engagement
CER 2016 Jacoby stakeholder engagementCER 2016 Jacoby stakeholder engagement
CER 2016 Jacoby stakeholder engagement
 
Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...
 
CER 2016 Trontell pcori cer presentation 2016 02 02 final
CER 2016 Trontell pcori cer presentation 2016 02 02 finalCER 2016 Trontell pcori cer presentation 2016 02 02 final
CER 2016 Trontell pcori cer presentation 2016 02 02 final
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
 
CER 2016 Dohan EQUIP
CER 2016 Dohan EQUIPCER 2016 Dohan EQUIP
CER 2016 Dohan EQUIP
 
CER 2016 Phillips cer symposium pcori 2016 from 012716
CER 2016 Phillips cer symposium pcori 2016 from 012716CER 2016 Phillips cer symposium pcori 2016 from 012716
CER 2016 Phillips cer symposium pcori 2016 from 012716
 
CER 2016 Hernandez patient engagement
CER 2016 Hernandez patient engagementCER 2016 Hernandez patient engagement
CER 2016 Hernandez patient engagement
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
 
CER 2016 Nguyen ctsi collaborative research
CER 2016 Nguyen ctsi collaborative researchCER 2016 Nguyen ctsi collaborative research
CER 2016 Nguyen ctsi collaborative research
 
Bridget Hopwood & Amanda Attwood
Bridget Hopwood & Amanda AttwoodBridget Hopwood & Amanda Attwood
Bridget Hopwood & Amanda Attwood
 
CSAS
CSASCSAS
CSAS
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseases
 
Budgeting for Patient Engagement (Nov 2020)
Budgeting for Patient Engagement (Nov 2020)Budgeting for Patient Engagement (Nov 2020)
Budgeting for Patient Engagement (Nov 2020)
 
SafeCare presentation 2013.06.07
SafeCare presentation 2013.06.07SafeCare presentation 2013.06.07
SafeCare presentation 2013.06.07
 
What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?
 

Semelhante a 0201b rachford using qualitative and quantitative data how to structure your research

Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
ExL Pharma
 
Risk of Bias_StaR Child Health Summit_07May12
Risk of Bias_StaR Child Health Summit_07May12Risk of Bias_StaR Child Health Summit_07May12
Risk of Bias_StaR Child Health Summit_07May12
michele_hamm
 
Conducting High Impact Research
Conducting High Impact ResearchConducting High Impact Research
Conducting High Impact Research
MEASURE Evaluation
 
1. Rate yourself according to your confidence level performing the
1. Rate yourself according to your confidence level performing the1. Rate yourself according to your confidence level performing the
1. Rate yourself according to your confidence level performing the
SantosConleyha
 
1. Rate yourself according to your confidence level performing the
1. Rate yourself according to your confidence level performing the1. Rate yourself according to your confidence level performing the
1. Rate yourself according to your confidence level performing the
AbbyWhyte974
 

Semelhante a 0201b rachford using qualitative and quantitative data how to structure your research (20)

0201 rachford pemberton w - using evidence to create advocacy impact 1.1
0201 rachford pemberton w - using evidence to create advocacy impact 1.10201 rachford pemberton w - using evidence to create advocacy impact 1.1
0201 rachford pemberton w - using evidence to create advocacy impact 1.1
 
0201a pemberton w how to create evidence for advocacy impact 1.1
0201a pemberton w   how to create evidence for advocacy impact 1.10201a pemberton w   how to create evidence for advocacy impact 1.1
0201a pemberton w how to create evidence for advocacy impact 1.1
 
Applying for funding and involving consumers
Applying for funding and involving consumersApplying for funding and involving consumers
Applying for funding and involving consumers
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
 
Involving patients in research what have we done and how did we do it jean ...
Involving patients in research   what have we done and how did we do it jean ...Involving patients in research   what have we done and how did we do it jean ...
Involving patients in research what have we done and how did we do it jean ...
 
Engage, Retain and Collect Data Directly from Patients in Late Phase Studies
Engage, Retain and Collect Data Directly from Patients in Late Phase StudiesEngage, Retain and Collect Data Directly from Patients in Late Phase Studies
Engage, Retain and Collect Data Directly from Patients in Late Phase Studies
 
high-impact-research-session-1-2011.pptx
high-impact-research-session-1-2011.pptxhigh-impact-research-session-1-2011.pptx
high-impact-research-session-1-2011.pptx
 
Risk of Bias_StaR Child Health Summit_07May12
Risk of Bias_StaR Child Health Summit_07May12Risk of Bias_StaR Child Health Summit_07May12
Risk of Bias_StaR Child Health Summit_07May12
 
Conducting High Impact Research
Conducting High Impact ResearchConducting High Impact Research
Conducting High Impact Research
 
2017 CAEP Academic Symposium Slides
2017 CAEP Academic Symposium Slides2017 CAEP Academic Symposium Slides
2017 CAEP Academic Symposium Slides
 
Using evidence in campaigning
Using evidence in campaigningUsing evidence in campaigning
Using evidence in campaigning
 
PCORI Methodology Workshop for Prioritizing Specific Research Topics
PCORI Methodology Workshop for Prioritizing Specific Research TopicsPCORI Methodology Workshop for Prioritizing Specific Research Topics
PCORI Methodology Workshop for Prioritizing Specific Research Topics
 
Equity, Health Quality and Shared Decision Making
Equity, Health Quality and Shared Decision MakingEquity, Health Quality and Shared Decision Making
Equity, Health Quality and Shared Decision Making
 
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
Keeping It Real:Resources for Implementing Evidence-based Public Health Progr...
 
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
 
Original Research
Original ResearchOriginal Research
Original Research
 
Engage and Retain Patients in Long-term Observational Studies
Engage and Retain Patients in Long-term Observational StudiesEngage and Retain Patients in Long-term Observational Studies
Engage and Retain Patients in Long-term Observational Studies
 
1. Rate yourself according to your confidence level performing the
1. Rate yourself according to your confidence level performing the1. Rate yourself according to your confidence level performing the
1. Rate yourself according to your confidence level performing the
 
1. Rate yourself according to your confidence level performing the
1. Rate yourself according to your confidence level performing the1. Rate yourself according to your confidence level performing the
1. Rate yourself according to your confidence level performing the
 
Levels of Engagement and Appropriate Methods
Levels of Engagement and Appropriate MethodsLevels of Engagement and Appropriate Methods
Levels of Engagement and Appropriate Methods
 

Mais de Workgroup of European Cancer Patient Advocacy Networks

Mais de Workgroup of European Cancer Patient Advocacy Networks (20)

Clinical Benefit from a patient's perspective
Clinical Benefit from a patient's perspective Clinical Benefit from a patient's perspective
Clinical Benefit from a patient's perspective
 
A patient perspective from the Cancer Mission Board.
A patient perspective from the Cancer Mission Board.A patient perspective from the Cancer Mission Board.
A patient perspective from the Cancer Mission Board.
 
Supporting rare cancer patients' journey through national cancer control plans
Supporting rare cancer patients' journey through national cancer control plansSupporting rare cancer patients' journey through national cancer control plans
Supporting rare cancer patients' journey through national cancer control plans
 
0201b rachford using qualitative and quantitative data how to structure you...
0201b rachford   using qualitative and quantitative data how to structure you...0201b rachford   using qualitative and quantitative data how to structure you...
0201b rachford using qualitative and quantitative data how to structure you...
 
0406 Spurrier and Ryll: Interpreting scientific data
0406   Spurrier and Ryll: Interpreting scientific data0406   Spurrier and Ryll: Interpreting scientific data
0406 Spurrier and Ryll: Interpreting scientific data
 
0207 1 Luca Mazzarella - precision medicine
0207 1 Luca Mazzarella - precision medicine0207 1 Luca Mazzarella - precision medicine
0207 1 Luca Mazzarella - precision medicine
 
0403 1 Stefan Weber - approaches to value and pricing
0403 1 Stefan Weber - approaches to value and pricing0403 1 Stefan Weber - approaches to value and pricing
0403 1 Stefan Weber - approaches to value and pricing
 
0407 Jan Geissler - WECAN Academy - What we have learned?
0407 Jan Geissler - WECAN Academy - What we have learned?0407 Jan Geissler - WECAN Academy - What we have learned?
0407 Jan Geissler - WECAN Academy - What we have learned?
 
0405 Bettina Rryll - The clinical trials we want!
0405  Bettina Rryll - The clinical trials we want! 0405  Bettina Rryll - The clinical trials we want!
0405 Bettina Rryll - The clinical trials we want!
 
0403 2 Zack PembertonW - Approaches to value and pricing
0403 2 Zack PembertonW - Approaches to value and pricing0403 2 Zack PembertonW - Approaches to value and pricing
0403 2 Zack PembertonW - Approaches to value and pricing
 
0402 Anna Wagstaff - Not being victim of hidden agenda
0402 Anna Wagstaff - Not being victim of hidden agenda0402 Anna Wagstaff - Not being victim of hidden agenda
0402 Anna Wagstaff - Not being victim of hidden agenda
 
0401 2 Ananda Plate - Patient Preferences
0401 2 Ananda Plate - Patient Preferences0401 2 Ananda Plate - Patient Preferences
0401 2 Ananda Plate - Patient Preferences
 
0401 1 Denis Costello - Patient Generated Data
0401 1 Denis Costello - Patient Generated Data0401 1 Denis Costello - Patient Generated Data
0401 1 Denis Costello - Patient Generated Data
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
 
0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO0306 2 Madelaine Pe - Analysing and Comparing PRO
0306 2 Madelaine Pe - Analysing and Comparing PRO
 
0306 1 Sergio Diaz - Patient Reported Outcomes
0306 1 Sergio Diaz - Patient Reported Outcomes0306 1 Sergio Diaz - Patient Reported Outcomes
0306 1 Sergio Diaz - Patient Reported Outcomes
 
0305 Spurrier - Ryll - Astratinei - Early access to new therapies spurrier - ...
0305 Spurrier - Ryll - Astratinei - Early access to new therapies spurrier - ...0305 Spurrier - Ryll - Astratinei - Early access to new therapies spurrier - ...
0305 Spurrier - Ryll - Astratinei - Early access to new therapies spurrier - ...
 
0304 Zack Pemberton - Influencing reimbursement decisions as a patient advocate
0304 Zack Pemberton - Influencing reimbursement decisions as a patient advocate0304 Zack Pemberton - Influencing reimbursement decisions as a patient advocate
0304 Zack Pemberton - Influencing reimbursement decisions as a patient advocate
 
0303 Julius Zaleskis - GDPR and data protection for cancer advocates
0303 Julius Zaleskis - GDPR and data protection for cancer advocates0303 Julius Zaleskis - GDPR and data protection for cancer advocates
0303 Julius Zaleskis - GDPR and data protection for cancer advocates
 
0302 Kathy Oliver - How not to bore your audience to death final
0302 Kathy Oliver - How not to bore your audience to death final0302 Kathy Oliver - How not to bore your audience to death final
0302 Kathy Oliver - How not to bore your audience to death final
 

Último

🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
 
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
mahaiklolahd
 

Último (20)

Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Majestic ⟟  9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Majestic ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Russian Call Girls Service Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
Russian Call Girls Service  Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...Russian Call Girls Service  Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
Russian Call Girls Service Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
 
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
 
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
Call Girls Visakhapatnam Just Call 8250077686 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 8250077686 Top Class Call Girl Service Ava...Call Girls Visakhapatnam Just Call 8250077686 Top Class Call Girl Service Ava...
Call Girls Visakhapatnam Just Call 8250077686 Top Class Call Girl Service Ava...
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
 

0201b rachford using qualitative and quantitative data how to structure your research

  • 1. Using qualitative and quantitative data: how to structure your research Daniel Ratchford Quality Health – Chief Executive daniel.ratchford@quality-health.co.uk or @danielratchford
  • 2. Quality Health A specialist health and social care research organisation, working for public, private and not-for profit sectors, in the UK and overseas  We design innovative data collection mechanisms to gather insight from patients, service users, staff and other stakeholders  We use our unique expertise and experience to collect, process, analyse and present information in the most meaningful ways  We work collaboratively with our clients to support service improvements, inform change, influence policy, and improve outcomes 25/10/2019 2 We help our clients achieve high quality and positive outcomes in health, social care and other services
  • 3. Key steps in generating data for Patient Advocacy Work out what the problem is  E.g. Do you have policy ideas you need to back up with evidence?  E.g. Do you want to test a theory about patient experience? Consider the bigger picture  What is already known?  Is there other relevant research?  Are other Patient Advocacy organisations planning anything similar? Have a clear analysis strategy  Make sure you know from the start how you will analyse the data  What exactly do you want to show, and to whom?  Will qualitative findings (e.g. stories) be more powerful than quantitative (e.g. numbers)? 25/10/2019 3 Be clear from the start how you want to use the data
  • 4. Good data can help your organisation to… Predict an outcome  E.g. If patients’ care is changed, how will this affect their overall wellbeing? Explain a cause or consequence  E.g. What has caused patients to report a drop in the standards of care? Evaluate policy  E.g. what has been the impact on patients of a change in policy or a new procedure? Describe service provision  E.g. What does high quality care look like from a patient perspective? Develop good practice  E.g. What do patients say would improve their care? Empower patients  E.g. What are the best ways to enhance patients’ lives, and the lives of patients in the future? 25/10/2019 4 Work out what your problem is: don’t just run a survey for the sake of it!
  • 5. Some good examples of focused patient advocacy research European Cancer Patient Coalition Cancer Associated Thrombosis Awareness Survey Aims:  To understand – and compare across countries – patients’ awareness of CAT  To map where, and when, patients get their information  To identify gaps of information and support during the patient pathway 25/10/2019 5
  • 6. Some good examples of focused patient advocacy research Acute Leukemia Advocates Network ALAN Quality of Life Survey Aims:  To understand the quality of life of acute leukaemia patients at different points in the patient journey 25/10/2019 6
  • 7. Some good examples of focused patient advocacy research All.Can International Survey of Waste and Inefficiency in Cancer Care Aims:  To gather the views of cancer patients and carers into areas of waste and inefficiency in cancer care  To gather examples of good practice, and areas for improvement 25/10/2019 7
  • 8. Some good examples of focused patient advocacy research CML Advocates Network CML Treatment Free Remission Survey Aims:  To understand the experiences of CML patients considering and undertaking Treatment Free Remission  To compare different patient groups  To consider the impact of different interventions and communications in this process 25/10/2019 8
  • 9. Main types of research to generate data Literature review and desk research  Reviewing the main ideas and research relating to your area of interest  Accessing existing relevant data sets Quantitative research  Questionnaires delivered on paper, on-line, in person or by phone  Structured interviewing Qualitative research  In-depth interviews, in person or by phone  Focus groups  Workshops 25/10/2019 9 Many of the most successful research programmes use a combination of the above
  • 10. Main types of research to generate data – pros and cons PROs Literature review and desk research  Well-respected academic approach  Relatively cheap  Doesn’t require external support Quantitative research  Best known and accepted research approach  Gathers views from many patients  Statistically significant results Qualitative research  Produces narrative rather than numbers  Stories, quotes, and films can have more impact in advocacy campaigns 25/10/2019 10 CONs Literature review and desk research  No new primary data  Access to academic papers expensive  Requires research skills Quantitative research  Can be expensive  Sampling bias often an issue  No depth behind the numbers Qualitative research  Expensive  Usually only involves small numbers  Difficult to argue it’s representative
  • 11. Typical research outputs  Data tables (from qualitative surveys)  Written commentaries of findings  Breakdowns  Powerpoint presentations  Infographics  Thematic analyses of qualitative research  Quotes from interviews  Films of patient stories  Improvement events  Formal papers for scientific journals  Press releases and advocacy campaigns 25/10/2019 11 You should be clear at the start about what you need, and how it will be used
  • 14. 25/10/2019 14 Main worries after the end of treatment * - by Gender *Respondents could select all answer options that applied (tick all that apply) Q7 / base = all respondents - What are the main worries you had after your treatment ended? Males (n=450) Females (n=560) Presentations: a breakdown
  • 20. Some common problems…and how to avoid them Not involving patients  Coproduction of research design  Patients and patient advocates on Steering Groups  Patients involved in reviewing and testing survey materials Not focusing on a specific issue - being too ambitious in scope  Identify the theme/issue you’re interested in  Keep it short  Don’t just run a survey for the sake of it! Not knowing what’s already been done  Talk to the experts  Carry out some form of literature review 25/10/2019 20
  • 21. Some common problems…and how to avoid them Not knowing what others are doing  Network with other patient advocacy groups, in other countries - It’s likely someone else is interested in the same issue Lack of testing and piloting before fieldwork  Don’t rush into implementation  Test survey materials thoroughly  Formal Cognitive Testing always identifies issues Asking the wrong people  Think about the sample of patients you want to hear from  Design your research framework to generate a representative sample  Don’t just listen to the same old voices 25/10/2019 21
  • 22. Some common problems…and how to avoid them Choosing the wrong delivery mechanism  Using an external agency can be expensive and add complexity  But carrying our research in-house risks lack of independence; and most organisations don’t have the skills and capacity  There will be times where both of these are right: consider carefully for each piece of research Not knowing how you’ll use the results  Be clear at the start about what you need, and how it will be used 25/10/2019 22 Talk as much as possible to other Patient Advocacy Groups about their experiences